Optical coherence tomography, commonly used in eye exams, can monitor neurodegeneration in Parkinson's disease patients by measuring the thickness of the retina. This method has revealed that retinal degeneration often precedes cognitive and motor decline, offering a potential early indicator of disease progression.
